report cover

Healthcare-associated Infectious Disease Diagnostics Market, Global Outlook and Forecast 2022-2028

  • 19 May 2022
  • Life Sciences
  • 102 Pages
  • Report code : 24WT-7089824

Healthcare-associated Infectious Disease Diagnostics and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Healthcare-associated Infectious Disease Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Healthcare-associated Infectious Disease Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Healthcare-associated Infectious Disease Diagnostics Overall Market Size
2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size: 2021 VS 2028
2.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Healthcare-associated Infectious Disease Diagnostics Players in Global Market
3.2 Top Global Healthcare-associated Infectious Disease Diagnostics Companies Ranked by Revenue
3.3 Global Healthcare-associated Infectious Disease Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Healthcare-associated Infectious Disease Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Healthcare-associated Infectious Disease Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Healthcare-associated Infectious Disease Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Healthcare-associated Infectious Disease Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Healthcare-associated Infectious Disease Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Healthcare-associated Infectious Disease Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Urinary Tract Infections
4.1.3 Surgical Site Infections
4.1.4 Hospital-acquired Pneumonia
4.1.5 BloodStream Infections
4.1.6 Gastrointestinal Infections
4.2 By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Healthcare-associated Infectious Disease Diagnostics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 ASCs
5.2 By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Healthcare-associated Infectious Disease Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Healthcare-associated Infectious Disease Diagnostics Revenue, 2017-2028
6.3.2 US Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.3.3 Canada Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.3.4 Mexico Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Healthcare-associated Infectious Disease Diagnostics Revenue, 2017-2028
6.4.2 Germany Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.4.3 France Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.4.4 U.K. Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.4.5 Italy Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.4.6 Russia Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.4.8 Benelux Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Healthcare-associated Infectious Disease Diagnostics Revenue, 2017-2028
6.5.2 China Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.5.3 Japan Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.5.4 South Korea Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.5.6 India Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Healthcare-associated Infectious Disease Diagnostics Revenue, 2017-2028
6.6.2 Brazil Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.6.3 Argentina Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue, 2017-2028
6.7.2 Turkey Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.7.3 Israel Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
6.7.5 UAE Healthcare-associated Infectious Disease Diagnostics Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.1.4 Abbott Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Accelerate Diagnostics
7.2.1 Accelerate Diagnostics Corporate Summary
7.2.2 Accelerate Diagnostics Business Overview
7.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.2.4 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Accelerate Diagnostics Key News
7.3 BD
7.3.1 BD Corporate Summary
7.3.2 BD Business Overview
7.3.3 BD Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.3.4 BD Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.3.5 BD Key News
7.4 bioMrieux
7.4.1 bioMrieux Corporate Summary
7.4.2 bioMrieux Business Overview
7.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.4.4 bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.4.5 bioMrieux Key News
7.5 Bio-Rad
7.5.1 Bio-Rad Corporate Summary
7.5.2 Bio-Rad Business Overview
7.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.5.4 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.5.5 Bio-Rad Key News
7.6 DiaSorin Molecular
7.6.1 DiaSorin Molecular Corporate Summary
7.6.2 DiaSorin Molecular Business Overview
7.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.6.4 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.6.5 DiaSorin Molecular Key News
7.7 F. Hoffmann-La Roche
7.7.1 F. Hoffmann-La Roche Corporate Summary
7.7.2 F. Hoffmann-La Roche Business Overview
7.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.7.4 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.7.5 F. Hoffmann-La Roche Key News
7.8 Luminex
7.8.1 Luminex Corporate Summary
7.8.2 Luminex Business Overview
7.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.8.4 Luminex Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.8.5 Luminex Key News
7.9 Meridian Bioscience
7.9.1 Meridian Bioscience Corporate Summary
7.9.2 Meridian Bioscience Business Overview
7.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.9.4 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.9.5 Meridian Bioscience Key News
7.10 OpGen
7.10.1 OpGen Corporate Summary
7.10.2 OpGen Business Overview
7.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.10.4 OpGen Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.10.5 OpGen Key News
7.11 QIAGEN
7.11.1 QIAGEN Corporate Summary
7.11.2 QIAGEN Business Overview
7.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.11.4 QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.11.5 QIAGEN Key News
7.12 Quidel
7.12.1 Quidel Corporate Summary
7.12.2 Quidel Business Overview
7.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.12.4 Quidel Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.12.5 Quidel Key News
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Corporate Summary
7.13.2 Thermo Fisher Scientific Business Overview
7.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.13.4 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.13.5 Thermo Fisher Scientific Key News
7.14 Trinity Biotech
7.14.1 Trinity Biotech Corporate Summary
7.14.2 Trinity Biotech Business Overview
7.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.14.4 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.14.5 Trinity Biotech Key News
7.15 Danaher
7.15.1 Danaher Corporate Summary
7.15.2 Danaher Business Overview
7.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Major Product Offerings
7.15.4 Danaher Healthcare-associated Infectious Disease Diagnostics Revenue in Global Market (2017-2022)
7.15.5 Danaher Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Healthcare-associated Infectious Disease Diagnostics Market Opportunities & Trends in Global Market
Table 2. Healthcare-associated Infectious Disease Diagnostics Market Drivers in Global Market
Table 3. Healthcare-associated Infectious Disease Diagnostics Market Restraints in Global Market
Table 4. Key Players of Healthcare-associated Infectious Disease Diagnostics in Global Market
Table 5. Top Healthcare-associated Infectious Disease Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Healthcare-associated Infectious Disease Diagnostics Product Type
Table 9. List of Global Tier 1 Healthcare-associated Infectious Disease Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Healthcare-associated Infectious Disease Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Healthcare-associated Infectious Disease Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Healthcare-associated Infectious Disease Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Healthcare-associated Infectious Disease Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Healthcare-associated Infectious Disease Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 32. Abbott Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Accelerate Diagnostics Corporate Summary
Table 34. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 35. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. BD Corporate Summary
Table 37. BD Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 38. BD Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. bioMrieux Corporate Summary
Table 40. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 41. bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Bio-Rad Corporate Summary
Table 43. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 44. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. DiaSorin Molecular Corporate Summary
Table 46. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 47. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. F. Hoffmann-La Roche Corporate Summary
Table 49. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 50. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Luminex Corporate Summary
Table 52. Luminex Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 53. Luminex Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Meridian Bioscience Corporate Summary
Table 55. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 56. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. OpGen Corporate Summary
Table 58. OpGen Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 59. OpGen Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. QIAGEN Corporate Summary
Table 61. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 62. QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 63. Quidel Corporate Summary
Table 64. Quidel Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 65. Quidel Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 66. Thermo Fisher Scientific Corporate Summary
Table 67. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 68. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 69. Trinity Biotech Corporate Summary
Table 70. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 71. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
Table 72. Danaher Corporate Summary
Table 73. Danaher Healthcare-associated Infectious Disease Diagnostics Product Offerings
Table 74. Danaher Healthcare-associated Infectious Disease Diagnostics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Healthcare-associated Infectious Disease Diagnostics Segment by Type in 2021
Figure 2. Healthcare-associated Infectious Disease Diagnostics Segment by Application in 2021
Figure 3. Global Healthcare-associated Infectious Disease Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Healthcare-associated Infectious Disease Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Healthcare-associated Infectious Disease Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2021
Figure 8. By Type - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Healthcare-associated Infectious Disease Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BD Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Luminex Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. OpGen Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Quidel Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Danaher Healthcare-associated Infectious Disease Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Healthcare-associated Infectious Disease Diagnostics and Forecast Market

Leave This Empty: